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The entire population of microorganisms
inhabiting both the external and internal surfaces of
a healthy organism is called normal microflora.
When factors affecting the balance of microflora,
such as mechanical injuries, diminished immunity, a
change in diet or climate come into play, the distur-
bance of balance between micro- and macroorgan-
ism takes place, leading to the development of infec-
tion and inflammation. The characteristic symptoms
of inflammation are erythema (rubor), pain (dolor),
edema (tumor), elevated body temperature (calor)
and dysfunction of organs (functio laesa) (1).
Immune system cells of different types, both seden-
tary and tissue-infiltrating, are involved in the
process of inflammation.
The major mediators of inflammation are
amines and biogenic amino acids (histamine and
serotonin), bradykinin, platelet-activating factor
(PAF), fragments of the complement (mainly C3a
and C5a), some cytokines, and arachidonic acid
derivatives. 
We observe the following pathological
responses to antigen: an excessively prolonged
response, a response inadequate to the degree of
exposure, or a response to the organism`s own anti-
gens. Stimulation of the immune system, originating
from a chronic inflammatory state, can negatively
affect quality of life or can cause a disease, cripple-
hood, and may even sometimes lead to death.
Therefore, studies focusing on potential antiinflam-
matory drugs are important for prevention of such
harmful consequences of immune system impair-
ment (2, 3).
Monocytes are the biggest leukocytes of diam-
eter up to 20 µm. They are formed in the bone mar-
row and then move into the bloodstream where they
circulate for ca. 24 h. Afterwards, they leave the cir-
culatory system and further differentiate in body tis-
sues where they develop into macrophages.
Monocytes together with macrophages constitute a
system whose basic biological role is phagocytosis.
Receptors of the stable fragment of immunoglobulin
G can be detected on the surface of monocytes. In
monocyteís Golgi apparatus the presence of peroxi-
dase can be demonstrated. Peroxidase plays an
important role in phagocytosis. Monocyte lyso-
somes contain a number of hydrolytic enzymes, e.g.,
arginase, deoxyribonuclease, elastase, β-glu-
curonidase, glucosidase, cathepsins, collagenase,
lipases, lysozyme and sulfatases. 
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Studies that examine the metabolic role of oxy-
gen, confirm its functional metabolic significance,
but also its toxicity. The toxicity is caused by for-
mation of reactive oxygen species (ROS) such as,
hyperoxide anion radical (O-ï), hydroxyl radical
(OHï), singlet oxygen, hydrogen peroxide and many
others. ROS play a number of important functions in
the organism, but under some conditions they can
also bring harmful consequences.
At the moment of their conctact with a
pathogen, phagocytizing cells produce ROS to pro-
tect the organism against pathogenic factors. On
such occasions, the presence of ROS in the place of
invasion plays an important protective role.
However, the uncontrolled increase in the concen-
trations of reactive oxygen metabolites, known as
oxidative stress, may have serious negative conse-
quences (4, 5). As a result of hyperoxide anion rad-
ical dismutation, hydrogen peroxide is formed. A
million neutrophilic granulocytes, stimulated with a
chemotactic peptide, produce at least 5.3 pmol of
hyperoxide anion radicals and 6.0 pmol of hydrogen
peroxide per second (6). 
Blood platelets, alias thrombocytes, are non-
nucleated granular cells, disc-like in shape, with a
diameter of 2ñ4 µm. Their number, under normal
conditions, ranges from 150 000 to 400 000 per 1 µL
in the circulating blood of an adult human.
Thrombocytes participate in the process of blood
clotting. In the locus of damage of the vascular wall
activation of blood platelets occurs, consisting of
release of cytokines, followed by formation of a
platelet ìplugî which inhibits bleeding. On their sur-
face, platelets accelerate the conversion of pro-
thrombin into thrombin; the latter plays a role in the
formation of a fibrin clot by retaining therein the
platelet plug and thus forming a more durable clot.
Activation of platelets may be induced by the con-
tact with leucocytes, predominantly neutrophils
stimulated by an inflammatory process (7). Platelets
initiate and maintain inflammatory processes by
releasing: a platelet-activating factor (PAF),
platelet-derived growth factor (PDGF), selectin P,
transforming growth factor β (TGFβ), platelet factor
4 (PF4), β-thromboglobulin, interleukin-1 (IL-1),
prostaglandins (PGs) (8, 9). Platelets are capable of
activating phagocytosis, increasing lysosome
degranulation and potentiating the cytotoxicity of
neutrophils and monocytes (10, 11).
During the inflammatory process, the blood
platelets in the organism are activated and affect
other morphotic components of blood. This in turn
triggers, among others, an interaction between
platelets and neutrophils and monocytes (12).
Platelets and monocytes can form platelet-monocyte
aggregates, mainly via platelet P-selectin and its lig-
and PSGL-1, but also via fibrinogen bridges
between glycoprotein Gp IIb/IIIa on blood platelets
and the corresponding integrin receptors Mac-1
present on monocytes. A fusion of this type may
facilitate interactions between cells (13). Mediators
effecting cell activation may be involved in these
interactions. The monocyte activation is expressed
by degranulation, an oxygen burst, chemotaxis or
phagocytosis. All these processes may be affected
by blood platelets through their release of such com-
pounds as PDGF, TGFβ, interleukins and throm-
boglobulins, as well as selectin P and PF4. Like neu-
trophils, also monocytes exert an effect on blood
platelets, among others by releasing PAF,
monokines, interleukins and cachectins. Based on
some reports it is assumed that cells of the immune
system may also participate in TXA2 biosynthesis
by providing blood platelets with arachidonic acid
(2, 14). The phenomenon of cooperation between
monocytes and blood platelets has not been studied
in detail so far.
The aim of the present study was: 
● to assess the metabolic activity of normal
monocytes in respect of their generation of ROS;
● to determine a possible relationship between
the activity of normal human monocytes and blood
platelets, and to estimate the ability of these cells to
generate ROS under in vitro conditions; 
● to study the response of cooperating cells in
the presence of nicotinamide, 1-methylnicotinamide
and 1-methyl-N`-hydroxymethylnicotinamide;
● to make a preliminary assessment of the




Nicotinamide and its derivatives
The tested compounds, i.e., β-pyridinecar-
boxylic acid amide (NA), 1-methylnicotinamide
(MNA+) and 1-methyl-Ní-hydroxymethylnicoti-
namide (MNAF+) were obtained from the Institute
of Applied Radiation Chemistry of the Technical
University of £Ûdü. The chemical structures of these
compounds are presented in Figure1. For the pur-
pose of measurement, the following concentrations
of the preparations in question were used: 1, 5, 10,
50, 100, 500 and 1000 µM. They were prepared as
described previously (15, 16). The aspirin (acetyl-
salicylic acid, ASA, Bayer) samples were obtained
from the Department of Experimental
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Pharmacology, Collegium Medicum, Jagiellonian
University in KrakÛw.
Latex (polystyrene particles) of diameter 0.9
µm came from the Institute of Catalysis and
Physicochemistry, Polish Academy of Sciences,
KrakÛw, Poland. A 10% of standard latex suspen-
sion in 10 µL was used for activation of cells.
Phosphate buffered saline (PBS) of the follow-
ing composition was used: monobasic sodium phos-
phate (0.2 M), dibasic sodium phosphate (0.2 M)
and sodium chloride (0.9%) adjusted to pH 7.4. 
All chemicals used in assays were of the high-
est purity available on the market.
Preparatione of buffer for chemiluminescence
The following reagents were mixed: 5 mL of a
luminol solution (0.0125 g of luminol, Sigma; 97%
pure by HPLC + 1.785 g Na2HPO4 ◊12 H2O + 50
mL of destilled water), 1 mL of the Krebs-Ringer
phosphate buffer, pH 7.4 concentrated fivefold, 3.8
mL of distilled water, 200 mL of glucose solution at
a concentration of 50 mg/mL. The buffer was pro-
tected from the light at a temperature of 4OC.
Chemiluminescence measurements
Chemiluminometry is a method used to assess
the functional state of immune system cells by
measuring their chemiluminescence (17, 18). It
consists in measuring the emitted light with scintil-
lation counters or luminometers equipped with a
photomultiplier. The number of photons emitted
during the chemiluminescence of the samples stud-
ied was measured with the microplate chemilumi-
nometer Berthold MicroLumat LB 96 P. The
results can be obtained in the form of curves show-
ing changes in luminescence intensity versus time
(19).
The results were recorded with a computer run-
ning WinGlow program (10, 20). The software
allows chemiluminescence experiment to be dis-
played on the basis of the following parameters: the
integration of the emmision curve; the maximum
value of the peak height in relative luminescence
units (RLU)/s and the time of reaching the maxi-
mum peak in minutes.
Biological material
Blood collected from healthy donors was cen-
trifuged to obtain platelet-rich plasma (PRP). Blood
platelets were obtained after two-fold PRP centrifu-
gation in the presence of prostaglandin J2 (PGJ2), (1
µL of prostaglandin per 2 mL of PRP). The centrifu-
gation was performed under the following conditions:
10 min, 1000 ◊ g at room temperature with
Eppendorf Centrifuge 5804 R. After the first centrifu-
gation, the supernatant was decanted and 2 mL of
PBS were added to the yielded deposit and mixed;
afterwards, the tube was supplemented with PBS up
to the previous volume and the appropriate amount of
PGJ2 was added. The mixture was centrifuged again
for 10 min at 800 ◊ g. After the second centrifugation,
the supernatant was decanted and 3 mL of PBS were
added to the final deposit. The counting of platelets
was performed as follows: 10 µL of the platelet sus-
pension was diluted 20-fold in a 3% polocaine. A few
drops of the solution containing the platelets were put
onto Thoma counting chamber and left for 10 min.
Then the platelets were counted under a microscope. 
The monocytes were isolated from blood col-
lected from healthy donors, the same as for platelets.
Figure 1. Chemical structure of the examined compounds
490 JACEK MI DZOBRODZKI et al.
The cells were isolated in the Department of
Immunology of the Jagiellonian University. For a
preliminary isolation of monocytes, the JE-6B appa-
ratus Elutriator System was used. The monocyte sus-
pension was placed in an Eppendorf tube, supple-
mented with PBS and centrifuged (the Eppendorf Lo
Bind Tubes Centrifuge 5415R) for 5 min at a tem-
perature of 4OC, 2000 rpm. The supernatant was
decanted, and the monocyte deposit was supple-
mented with PBS and re-centrifuged twice under the
same conditions. After the third centrifugation, the
supernatant was decanted and the deposit was sup-
plemented with PBS to obtain 5 millions monocytes
per 1 mL volume. The isolated cells were kept on ice
since an increase in temperature is a factor activat-
ing monocytes and leading to a decrease in their
activity. 
RESULTS
Samples containing cells or cells with tested
compounds but without activator were used as neg-
Figure 2. Control experiments ñ activation of monocytes and monocytes with platelets by latex
Figure 3. The effect of aspirin (ASA) on the activated human monocytes cooperating with blood platelets 
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ative control, whereas monocytes activated with
polystyrene particles served as positive control. The
chemiluminescence levels for samples containing
only blood platelets were close to zero. The blood
platelets stimulated with polystyrene particles
showed chemiluminescene values that were a few
per cent higher compared to the values for platelets
without an activator. Monocytes activated by latex
particles resulted in an increase in chemilumines-
cence level, and additionally the presence of
platelets in monocyte suspension displayed a more
considerable increase in chemiluminescence after
stimulation by latex, as it is shown in Figure. 2. The
results presented in Figure 3 show that the addition
of aspirin to activated human monocytes cooperat-
ing with blood platelets decreased the generation of
radical oxygen species which was expressed as sig-
nificant lower chemiluminescence (CL) level. 
The results for NA, MNA+ and MNAF+ are
shown in Figures 4, 5, and 6, respectevely. The
obtained results were compared to the data acquired
for ASA (Fig. 3).
The addition of NA to monocytes cooperating
with blood platelets caused a slight decrease in CL
Figure 4. The effect of nicotinamide (NA) on the activated human monocytes cooperating with blood platelets
Figure 5. The effect of 1-methylnicotinamide (MNA+) on the activated human monocytes cooperating with blood platelets
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levels (Fig. 4). The use of MNA+ to stimulate the
latex-activated monocytes cooperating with blood
platelets yielded results similar to those obtained
with NA (Fig. 5) and Figure 6 demonstrates that the
addition of MNAF+ to the cooperating monocytes
with blood platelets produced results analogous to
those shown for aspirin (Fig. 3). It was observed that
MNAF+ strongly inhibited the generation of ROS by
monocytes which was expressed by low chemilumi-
nescence level. 
DISCUSSION AND CONCLUSION
During an inflammatory process, complex
interactions of monocytes and neutrophils with
blood platelets take place in the organism, however,
these interactions have not been studied in detail.
The available literature provides evidence of diverse
impact of blood platelets on chemotaxis, phagocyto-
sis, degranulation and the oxygen metabolism of
blood cells. Similarly, neutrophils as well as mono-
cytes can influence the adhesion, aggregation and
secretion of different agents from blood platelets
(13).
Human monocyte and blood platelets were
used to carry out the studies under in vitro condi-
tions. The cells were activated with latex (poly-
styrene particles). Its considerable impact on cells
causes their activation, expressed as stimulation of a
number of biochemical reactions. When supple-
mented with that activator, monocytes showed a
considerable increase in CL both when used alone
and in cooperation with blood platelets. Based on
the results of experiments conducted by other
researchers (19, 21), it may be assumed that the
cause of the increased chemiluminescence was the
acceleration of the formation of ROS.
Our study was aimed to analyze interactions
between monocytes and blood platelets in the
process of generation of ROS by monocytes. In
samples containing both monocytes and platelets,
the CL value was considerably higher than the value
recorded for activated monocytes or blood platelets
separately. The present results confirm earlier
reports that the cooperation of monocytes with
blood platelets potentiates chemiluminescence
which originates from an increase in the number of
generated ROS. It was also observed that the CL
value of blood platelets stimulated with polystyrene
particles was slightly higher (by a few per cent) than
the CL value of unactivated cells. The above find-
ings seem to confirm that blood platelets are not
equipped with a mechanism of oxygen killing. The
weak light emission by blood platelets alone has
permitted us to propose that the increased CL value
of monocyte and blood platelets aggregates origi-
nates mainly from monocytes, and to a limited
extent from blood platelets. 
The addition of aspirin (ASA) to cooperating
monocytes and blood platelets led to a decrease in
the CL value of the studied cells. Aspirin is a com-
monly used non-steroid antiinflammatory (NSAI)
drug. It inhibits cyclooxygenase (COX)-1 activity
by hindering the generation of prostanoids in the
Figure 6. The effect of 1-methyl-Ní-hydroxymethylnicotinamide (MNAF+) on the activated human monocytes cooperating with blood
platelets
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first phase of their biosynthesis from arachidonic
acid (2, 22), which accounts for the observed
decrease in CL. The obtained results clearly indicate
that the rise in drug concentration is accompanied by
a decrease in CL. When used in higher doses, aspirin
causes a decrease in the activity of monocytes gen-
erating ROS. The CL of the cell aggregates under
study, stimulated with a high dose of the drug, was
lower than the CL of unactivated monocytes. 
The addition of MNAF+ to the cooperating mono-
cytes and blood platelets produced a result analo-
gous to that shown for aspirin. It was observed that
MNAF+ inhibited the generation of ROS by mono-
cytes. Like in the case of ASA, the higher was the
dose of the substance, the lower was the activity of
monocytes cooperating with blood platelets.
MNAF+ concentrations higher than 0.5 mM caused
a drop in the CL values of the cells examined below
the value of the CL of unactivated monocytes.
The addition of NA, commonly known as vita-
min B3 to monocytes cooperating with blood
platelets, caused a decrease in CL value. In contrast
to the previously discussed substances, NA ñ inde-
pendently of the dose used ñ decreased the CL of the
examined cells. However, the obtained CL values
never fell below those of the CL of unactivated
monocytes. NA is recognized for its antiinflamma-
tory action; it is commonly used and supplied to the
organism with food. Therefore, further studies are
necessary to estimate the natural levels of NA pres-
ent in monocytes. 
The use of MNA+ to stimulate the latex-acti-
vated monocytes cooperating with blood platelets
yielded results very close to those obtained with
nicotinamide. The only difference was that the
degree of inhibition of monocyte activity in their
generation of oxygen free radicals was inconsider-
ably larger than in the case of nicotinamide. 
The results shown for the respective measure-
ments, concerning the effect of the same chemical
compound ñ a nicotinamide derivative ñ on CL, dif-
fer considerably, which leads to an increase in vari-
ance value. The latter phenomenon is most probably
due to considerable individual differences in cell
donors. Under normal conditions, the response to an
antigen depends to a large extent on the individualís
genetic predispositions, physical condition, lifestyle,
diet and a number of other factors. Also the response
to drugs depends upon all the above-mentioned fac-
tors which may significantly modify the efficiency
of drugs, their activity time, the rate of elimination
from the organism and other variables. 
Our results originating from all the experi-
ments demonstrated an activated state of monocytes,
expressed as the ability of those cells to respond to
an external stimulus by increasing the numer of gen-
erated ROS. The evidence for the existence of a high
functional potential of monocytes came from their
response to stimulation with polystyrene particles.
The study showed that, like aspirin, MNAF+ inhibit-
ed the generation of ROS by the cooperating mono-
cytes and blood platelets, and that substances such
as nicotinamide and methylnicotinamide decreased
the activity of human monocytes.
The results obtained in the experimental series
with nicotinamide and its derivatives are promising.
They have demonstrated the possibility of using these
compounds in the future as a basis for the production
of non-steroidal antiinflammatory drugs which could
be used in rheumatic diseases, or as analgesic drugs in
degenerative joint diseases, parodontosis, sports
injuries, menstrual colic and others. There have also
been an increasing number of reports stating that
these drugs may be useful in the prophylaxis of col-
orectal carcinoma and other neoplasms, as well as in
the prevention of Alzheimer`s disease and the thera-
py of imminent premature child birth. Nonetheless,
further studies should be carried out before introduc-
ing these compounds into clinical practice. 
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